(UNI) Pharma Major Lupin said that it has received tentative approval for its Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mg from the United States Food and Drug
Administration (FDA) to market a generic version of Biogen, Inc’s Tecfidera Capsules, 120 mg and 240 mg.
Lupin’s Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mg is the generic version of Biogen, Inc’s Tecfidera Capsules, 120 mg and 240 mg.
